The University of Michigan Comprehensive Cancer Center has developed an app that enables doctors to more easily customize treatment plans and lets patients track treatment progress.
Called Breast Cancer Ally, the application was developed after gathering feedback from both specialists who cared for patients and patients themselves, to create a tool both parties would benefit from.
The center hopes to launch similar apps, targeting more conditions, such as melanoma, prostate cancer and colorectal cancer.If proves useful, the center hopes to launch similar apps, targeting more conditions, such as melanoma, prostate cancer and colorectal cancer. Those apps will debut in early 2016 and reflect the center’s strategy to create a suite of software for cancer treatments.
“In the future, these technologies will be even more important as therapy becomes more directed through genomics,” Michael Sabel, M.D., a breast cancer surgeon who directed app development, told Cancer Therapy Advisor. “These patient navigation apps can help filter the educational material based on the patient’s genomic profile so that targeted therapy is merged with targeted education.”
Using apps to help patients cope with their treatments is a novel idea many companies and institutions are exploring. This spring, MD Anderson Cancer Center at Cooper announced plans to deploy Apple Watches with preloaded custom app to breast cancer patients in a pilot program to track behavioral information for ensure treatment programs remain on target. More recently, Roche and Voluntis teamed-up over a mobile therapy for breast cancer.